TOG Review (RCOG Journal)

MRCOG Part 2

Gynaecological Problems

Polycystic ovary syndrome and the differential diagnosis of hyperandrogenism

Key Statistics

  • 10–20% — Women of reproductive age with PCOS
  • 2–5 nmol/L — Testosterone typical of PCOS
  • >5 nmol/L — Testosterone — Investigate other cause

Don't-miss facts

  1. PCOS testosterone 2–5 nmol/L; >5 nmol/L → investigate for tumour/other cause

  2. Immunoassay can overestimate female testosterone by up to 100% – MS is gold standard but not widely available

  3. Rotterdam: 2 of 3 – oligomenorrhoea/anovulation; clinical/biochemical hyperandrogenism; ovarian volume >10 ml on US – exclude other causes first

  4. Ferriman-Gallwey ≥8 = hirsutism (11 sites, 0–4 scale)

  5. Ovarian hyperthecosis: testosterone can exceed 7 nmol/L; main cause of postmenopausal hyperandrogenaemia

  6. 21-hydroxylase deficiency = 90–95% of CAH; non-classic form: 20–60% function, no salt-wasting, ~2% of female hyperandrogenism

  7. Ovarian androgen tumour: ↑testosterone + normal DHEA-S/17-ketosteroids; adrenal tumour: not suppressed by dexamethasone

  8. Gestational hyperandrogenism: rare, mostly luteoma/theca lutein cysts; solid unilateral lesion = ↑malignancy risk

Differential diagnoses (box 2)

PCOS Ovarian hyperthecosis CAH Cushing’s syndrome Androgen-secreting tumour Exogenous androgens

Gestational hyperandrogenism

Abbreviation Key

  • PCOS — polycystic ovary syndrome
  • LH — luteinising hormone
  • DHEA — dehydroepiandrosterone
  • FSH — follicle stimulating hormone
  • DHEA-S — DHEA-sulfate
  • GnRH — gonadotrophin releasing hormone
  • SHBG — sex hormone binding globulin
  • IGF-1 — insulin-like growth factor-1
  • DHT — dihydrotestosterone
  • AMH — anti-müllerian hormone
  • CAH — congenital adrenal hyperplasia
  • NASH — non-alcoholic steatohepatitis
  • ACTH — adrenocorticotrophic hormone
  • MS — mass spectrometry
  • CRH — corticotrophin releasing hormone
  • CT/MRI/US — computerised tomography / magnetic resonance imaging / ultrasound

Source: Meek CL et al. Polycystic ovary syndrome and the differential diagnosis of hyperandrogenism. The Obstetrician & Gynaecologist 2013;15:171–176. doi:10.1111/tog.12030

MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).

Included with a Pass Package

  • Audio overview of this guideline
  • Practice questions drawn from it
  • AI tutor answers grounded in its text
  • Your own annotations
Start free